RADL.Y Stock Overview

Engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. More details

RADL.Y fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	5/6
Past Performance	2/6
Financial Health	4/6
Dividends	4/6

Rewards

Trading at 12.2% below our estimate of its fair value

Earnings are forecast to grow 20.34% per year

Earnings have grown 12.2% per year over the past 5 years

Risk Analysis

Highly volatile share price over the past 3 months compared to the US market

Has a high level of debt

My Notes

Capture your thoughts, links and company narrative

Raia Drogasil S.A. Competitors

Maplebear

NasdaqGS:CART

US$11.1b

Performance Food Group

NYSE:PFGC

US$13.1b

Albertsons Companies

NYSE:ACI

US$11.4b

BJ's Wholesale Club Holdings

NYSE:BJ

US$11.7b

Price History & Performance

Summary of share price highs, lows and changes for Raia Drogasil
Historical stock prices
Current Share Price	R$3.61
52 Week High	R$14.00
52 Week Low	R$3.11
Beta	0.33
1 Month Change	-21.35%
3 Month Change	-23.35%
1 Year Change	-43.15%
3 Year Change	-5.40%
5 Year Change	-33.96%
Change since IPO	-6.04%

Recent updates

Shareholder Returns

	RADL.Y	US Consumer Retailing	US Market
7D	-1.1%	-1.3%	-0.2%
1Y	-43.1%	41.5%	25.6%

Return vs Industry: RADL.Y underperformed the US Consumer Retailing industry which returned 41.3% over the past year.

Return vs Market: RADL.Y underperformed the US Market which returned 24.1% over the past year.

Price Volatility

Is RADL.Y's price volatile compared to industry and market?
RADL.Y volatility
RADL.Y Average Weekly Movement	19.4%
Consumer Retailing Industry Average Movement	5.8%
Market Average Movement	6.3%
10% most volatile stocks in US Market	18.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: RADL.Y's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: RADL.Y's weekly volatility has decreased from 26% to 19% over the past year, but is still higher than 75% of US stocks.

About the Company

Founded	Employees	CEO	Website
1905	62,402	Marcílio Pousada	rdsaude.com.br

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It sells its products through stores, telesales, and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

Raia Drogasil S.A. Fundamentals Summary

How do Raia Drogasil's earnings and revenue compare to its market cap?
RADL.Y fundamental statistics
Market cap	US$6.03b
Earnings (TTM)	US$179.51m
Revenue (TTM)	US$6.10b

32.1x

P/E Ratio

0.9x

P/S Ratio

Is RADL.Y overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RADL.Y income statement (TTM)
Revenue	R$37.70b
Cost of Revenue	R$26.45b
Gross Profit	R$11.25b
Other Expenses	R$10.14b
Earnings	R$1.11b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.65
Gross Margin	29.83%
Net Profit Margin	2.95%
Debt/Equity Ratio	51.8%

How did RADL.Y perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

51%

Payout Ratio

Does RADL.Y pay a reliable dividends?

See RADL.Y dividend history and benchmarks

When do you need to buy RADL.Y by to receive an upcoming dividend?
Raia Drogasil dividend dates
Ex Dividend Date	Oct 15 2024
Dividend Pay Date	Jun 09 2025
Days until Ex dividend	82 days
Days until Dividend pay date	155 days

Does RADL.Y pay a reliable dividends?

See RADL.Y dividend history and benchmarks

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/03 00:00
End of Day Share Price	2025/01/03 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Raia Drogasil S.A. is covered by 30 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Georgia Jorge	BB Banco de Investimento S.A.
Robert Ford Aguilar	BofA Global Research
Marcio Osako	Bradesco S.A. Corretora de Títulos e Valores Mobiliários